Follow
Paul Sabbatini
Paul Sabbatini
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ...
Nature medicine 23 (6), 703-713, 2017
28922017
Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial
E Basch, AM Deal, MG Kris, HI Scher, CA Hudis, P Sabbatini, L Rogak, ...
Journal of Clinical Oncology 34 (6), 557, 2016
21232016
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
18982017
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial
ML Hensley, R Maki, E Venkatraman, G Geller, M Lovegren, ...
Journal of Clinical Oncology 20 (12), 2824-2831, 2002
8082002
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study
ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ...
Journal of clinical oncology 26 (8), 1331, 2008
7042008
NCCN Practice Guidelines for Cancer-Related Fatigue.
V Mock, A Atkinson, A Barsevick, D Cella, B Cimprich, C Cleeland, ...
Oncology (Williston Park, NY) 14 (11A), 151-161, 2000
6552000
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies
C Aghajanian, S Soignet, DS Dizon, CS Pien, J Adams, PJ Elliott, ...
Clinical cancer research 8 (8), 2505-2511, 2002
6112002
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study …
RL Coleman, MF Brady, TJ Herzog, P Sabbatini, DK Armstrong, JL Walker, ...
The Lancet Oncology 18 (6), 779-791, 2017
5942017
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
DS Chi, CC Franklin, DA Levine, F Akselrod, P Sabbatini, WR Jarnagin, ...
Gynecologic oncology 94 (3), 650-654, 2004
3772004
Patient online self-reporting of toxicity symptoms during chemotherapy
E Basch, D Artz, D Dulko, K Scher, P Sabbatini, M Hensley, N Mitra, ...
Journal of clinIcal oncology 23 (15), 3552-3561, 2005
3412005
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset
DO Hardy, HI Scher, T Bogenreider, P Sabbatini, ZF Zhang, DM Nanus, ...
The Journal of Clinical Endocrinology & Metabolism 81 (12), 4400-4405, 1996
3291996
Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology
RJ Morgan, DK Armstrong, RD Alvarez, JN Bakkum-Gamez, K Behbakht, ...
Journal of the National Comprehensive Cancer Network 14 (9), 1134-1163, 2016
3222016
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
P Sabbatini, T Tsuji, L Ferran, E Ritter, C Sedrak, K Tuballes, ...
Clinical cancer research 18 (23), 6497-6508, 2012
3142012
Secondary surgical cytoreduction for recurrent ovarian cancer
RL Coleman, NM Spirtos, D Enserro, TJ Herzog, P Sabbatini, ...
New England Journal of Medicine 381 (20), 1929-1939, 2019
2882019
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer
P Sabbatini, SM Larson, A Kremer, ZF Zhang, M Sun, H Yeung, ...
Journal of clinical oncology 17 (3), 948-948, 1999
2811999
Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: results of a prospective study
ML Hensley, N Ishill, R Soslow, J Larkin, N Abu-Rustum, P Sabbatini, ...
Gynecologic oncology 112 (3), 563-567, 2009
2432009
NCCN guidelines insights: Ovarian cancer, version 1.2019: Featured updates to the NCCN guidelines
DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ...
Journal of the National Comprehensive Cancer Network 17 (8), 896-909, 2019
2312019
Early detection and prognosis of ovarian cancer using serum YKL-40
J Dupont, MK Tanwar, HT Thaler, M Fleisher, N Kauff, ML Hensley, ...
Journal of clinical oncology 22 (16), 3330-3339, 2004
1972004
Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II)
S Reinartz, S Köhler, H Schlebusch, K Krista, P Giffels, K Renke, ...
Clinical Cancer Research 10 (5), 1580-1587, 2004
1942004
Farletuzumab, a humanized monoclonal antibody against folate receptor α, in epithelial ovarian cancer: a phase I study
JA Konner, KM Bell-McGuinn, P Sabbatini, ML Hensley, WP Tew, ...
Clinical Cancer Research 16 (21), 5288-5295, 2010
1862010
The system can't perform the operation now. Try again later.
Articles 1–20